Legend Biotech Corp (LEGN) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
LEGN Profit Margin, ROE & Profitability Analysis
LEGN vs Healthcare Sector: How Legend Biotech Corp Compares
How Legend Biotech Corp compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Legend Biotech Corp Stock Overvalued? LEGN Valuation Analysis 2026
Based on fundamental analysis, Legend Biotech Corp has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Legend Biotech Corp Balance Sheet: LEGN Debt, Cash & Liquidity
LEGN Revenue Growth, EPS Growth & YoY Performance
LEGN SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Legend Biotech Corp (CIK: 0001801198)
📋 Recent SEC Filings
❓ Frequently Asked Questions about LEGN
What is the AI rating for LEGN?
Legend Biotech Corp (LEGN) has an AI grade of N/A with 0% confidence, based on fundamental analysis of SEC EDGAR filings.
What are LEGN's key strengths?
Claude: Analysis in progress.
What are the risks of investing in LEGN?
Claude: Analysis in progress.
What is LEGN's revenue and growth?
Legend Biotech Corp reported revenue of N/A.
Does LEGN pay dividends?
Legend Biotech Corp does not currently pay dividends.
Where can I find LEGN SEC filings?
Official SEC filings for Legend Biotech Corp (CIK: 0001801198) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is LEGN's EPS?
Legend Biotech Corp has a diluted EPS of $0.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is LEGN's fundamental grade?
Based on our AI fundamental analysis in May 2026, Legend Biotech Corp has a N/A grade with 0% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is LEGN stock overvalued or undervalued?
Valuation metrics for LEGN: ROE of N/A (sector avg: 15%), net margin of N/A (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
What is LEGN's AI grade for 2026?
Our dual AI analysis gives Legend Biotech Corp a combined N/A grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is LEGN's free cash flow?
Legend Biotech Corp's operating cash flow is N/A, with capital expenditures of N/A.
How does LEGN compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin N/A (avg: 12%), ROE N/A (avg: 15%), current ratio N/A (avg: 2).